Vaginal progesterone for the prevention of preterm birth in twin gestations: a randomized placebo-controlled double-blind study.
Brizot, Maria L; Hernandez, Wagner; Liao, Adolfo W; Bittar, Roberto E; Francisco, Rossana P V; Krebs, Vera L J; Zugaib, Marcelo.
Am J Obstet Gynecol
; 213(1): 82.e1-82.e9, 2015 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-25731690
Prenatal administration of progestogens for preventing spontaneous preterm birth in women with a multiple pregnancy.
Safety and efficacy of the cervical pessary combined with vaginal progesterone for the prevention of spontaneous preterm birth.
Plasma progesterone, estradiol, and unconjugated estriol concentrations in twin pregnancies: Relation with cervical length and preterm delivery.
A randomised trial to compare 200 mg micronised progesterone effervescent vaginal tablet daily with 250 mg intramuscular 17 alpha hydroxy progesterone caproate weekly for prevention of recurrent preterm birth.
Progestogens and prevention of preterm birth in women at risk.
Prenatal administration of vaginal progesterone and frequency of uterine contractions in asymptomatic twin pregnancies.
Prevention of preterm birth with pessary in singletons (PoPPS): randomized controlled trial.
Vaginal progesterone is as effective as cervical cerclage to prevent preterm birth in women with a singleton gestation, previous spontaneous preterm birth, and a short cervix: updated indirect comparison meta-analysis.
Increased doses of vaginal progesterone for the prevention of preterm birth in twin pregnancies: a randomised controlled double-blind multicentre trial.
Vaginal progesterone decreases preterm birth ≤ 34 weeks of gestation in women with a singleton pregnancy and a short cervix: an updated meta-analysis including data from the OPPTIMUM study.